The Crystal Structure of an Anti-CEA scFv Diabody Assembled from T84.66 scFvs in VL-to-VH Orientation: Implications for Diabody Flexibility
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 326 (2), 341-351
- https://doi.org/10.1016/s0022-2836(02)01428-6
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II studyBritish Journal of Cancer, 2002
- Improving the efficacy of antibody-based cancer therapiesNature Reviews Cancer, 2001
- Dimeric and trimeric antibodies: high avidity scFvs for cancer targetingBiomolecular Engineering, 2001
- Recombinant antibodies for cancer diagnosis and therapyExpert Opinion on Biological Therapy, 2001
- Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vectorCancer Immunology, Immunotherapy, 2001
- Tumor Targeting of Mono-, Di-, and Tetravalent Anti-p185HER-2 Miniantibodies Multimerized by Self-associating PeptidesJournal of Biological Chemistry, 2001
- Tumor Targeting of Radiometal Labeled Anti-CEA Recombinant T84.66 Diabody and T84.66 Minibody: Comparison to Radioiodinated FragmentsBioconjugate Chemistry, 2001
- Design and application of diabodies, triabodies and tetrabodies for cancer targetingJournal of Immunological Methods, 2001
- [28] Methods for generating multivalent and bispecific antibody fragmentsMethods in Enzymology, 2000
- New protein engineering approaches to multivalent and bispecific antibody fragmentsImmunotechnology, 1997